Precision medicine is now a reality.
AcroCyte is ready to provide essential solutions for all medical trends of the future.
Rapid Reproducible Rare Cell 3D Expansion (R3CE):
• Enables culture of 3D tissues from a single cell
• Capacity to build ex vivo 3D models from all types of samples
• Efficiently and reliably culture rare cells
The 3Rs-– refine, reduce, and replace-- are the systematic approach regulators and institutions are taking towards improving animal welfare in scientific research. EU has already banned animal research on cosmetics back in 2013, and the US EPA has announced that it will eliminate all mammal testing by 2035. The 3Rs are expected to be increasing commonplace in the future, and it’s up to the companies to keep up. AcroCyte Therapeutics was established to transform your research with animal-free models.AcroCyte Therapeutics can help by providing animal-free research and testing solutions. Accelerate your drug development, product design, and scientific research with us today.
Often times, cell therapy experiments are conducted with monolayer culture, resulting in successful but invalid results.
AcroCyte Therapeutics can accurately validate cell therapy tests with 3D models.
R3CE is the breakthrough technology that can culture 3D tissues from one single cell. Culture rare cells, stem cells, and even CTCs with speed and consistency. Accelerate clinical drug discovery and make treatment decisions in time with R3CE.
